Objective: To characterise risk factors for abnormal anal cytology and anal human papilloma virus (HPV) Introduction Before the human immunodeficiency virus (HIV) epidemic, the incidence of anal cancer was estimated to be approximately 35/100 000 among men with a history of receptive anal intercourse.' This incidence is similar to that of cervical cancer in women before the introduction of cervical cytology screening and several times higher than current cervical cancer rates.2 The past 20 years have seen an increase in the incidence of anal cancer in this group, although the degree to which HIV related immunosuppression has contributed to this
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Before the human immunodeficiency virus (HIV) epidemic, the incidence of anal cancer was estimated to be approximately 35/100 000 among men with a history of receptive anal intercourse.' This incidence is similar to that of cervical cancer in women before the introduction of cervical cytology screening and several times higher than current cervical cancer rates. 2 The past 20 years have seen an increase in the incidence of anal cancer in this group, although the degree to which HIV related immunosuppression has contributed to this increase is unclear. 34 Much of the decrease in cervical cancer rates among women in the past few decades has been attributed to the introduction of routine screening for precancerous cervical disease. Detection of a lesion on cervical cytology, such as a high grade squamous intraepithelial lesion (HSIL), typically results in referral for colposcopy, colposcopy directed biopsy, and treatment of the lesion, and theoretically preventing progression of the lesion to invasive cancer.
There are many biological similarities between cervical and anal cancer5 that lend themselves to the use of anal cytology for detection and treatment of potentially precancerous anal disease. Among these similarities is a strong association with human papilloma virus (HPV) infection. 5 As described in a recent review, several HPV types are known to infect the anogenital tract. HPV 16 and 18 are most strongly associated with HSIL and invasive cancer, whereas types 6, 11, 42, 43, or Previous studies have shown that anal squamous intraepithelial lesions (ASIL) are more common among HIV positive men than among HIV negative men, especially among those HIV positive men with lower CD4 counts.9 12 Similarly, anal HPV infection is more common in HIV positive men with lower CD4 counts." [1] [2] [3] [4] [5] HIV related immunosuppression and infection with HPV 16 or 18 are predictive of HSIL development'6 among men followed prospectively. Lastly, recent data have shown that anal HPV infection and HPV related disease are more common in HIV positive women than in HIV negative women, and both are associated with lower CD4 levels in the HIV positive women. '7 Other than HIV related immunosuppression and HPV infection, behavioural and biological risk factors for anal disease are poorly understood. A recent study conducted in Jamaica showed that seropositivity to human T cell leukaemia virus (HTLV)-1 was a pre- groups.
RISK FACTORS FOR ABNORMAL ANAL CYTOLOGY
In this study, there were high rates of HPV positivity using both PCR and HC. Because many subjects had multiple types, "type specific" analyses should be interpreted cautiously. Overall, HPV infection using PCR was associated with abnormal cytology (p = 0.04, Fisher's exact test). Each of the seven subjects who was PCR negative and the 11 subjects who had only unknown HPV types had normal anal cytology. The RR for abnormal cytology measured by PCR was separately calculated for HPV 6/11 (RR = 1-5, CI = Overall, a positive HC result was associated with abnormal anal cytology (p < 0.001, x2). The RR for abnormal cytology using HC was elevated for all groups except HPV 42/43/44 (RR = 1-2, CI = 0.73-1.9). The highest RRs were associated with HPV 31/33/35 (RR = 2.6, CI = 1.6-4-2) and 16/18 (RR = 2-2, CI = 1-4-3-3), followed by 6/11 (RR = 1.9, CI = 1-3-2-9) and 45/51/52/56 (RR = 1-7, CI = 1 -1-2-6). Infection with a group B type by HC was associated with a higher RR for abnormal anal cytology than infection with a group A type; however, the CI for each of these groups were wide (table 2). The risk of abnormal anal cytology increased with higher HC RLU ratios for both group A and B, with the highest risk associated with higher levels of group B (table 2) .
Lifestyle factors and health status associated with abnormal anal cytology are presented in table 3 . Lower CD4 counts and other markers of immune suppression such as oral thrush were significantly associated with abnormal anal cytology. Of the medications for AIDS associated illnesses examined, only trimethoprim-sulphamethoxazole (RR = 1-8, 95% CI = 1-2-2-8) was associated with abnormal anal cytology. Smoking, alcohol use, recreational,
Among the sexual behaviours studied, only "fisting" was significantly associated with abnormal anal cytology ( Plasma antibodies to HTLV-1 were measured for all subjects. Only three of 129 (2%) subjects were positive for HTLV-1 and none of these subjects gave a history of intravenous In this report, we characterised risk factors for anal disease and anal HPV infection among men at high risk-that is, those with CDC defined group IV HIV disease. Since the biological characteristics of this study population differ from an HIV negative population or a population that spans a wider spectrum of HIV disease, the findings of this study may not be generalisable to the general population of homosexual men.
In this group of men with advanced HIV related immunosuppression, anal cytological abnormalities were found in nearly 40% of the population, a level similar to that in an earlier study of a different group of men with symptomatic HIV disease.'0 A high proportion of the abnormal cytologies were ASCUS in the current study. Justification for inclusion of ASCUS into the "abnormal" category includes data from previous work'0 showing that the proportion of specimens with ASCUS containing HPV infection is similar to that with higher grades of cytological abnormality. In addition, approximately half of men with ASCUS on cytology have concurrent biopsy proved anal disease (J M Palefsky, unpublished data).
HPV infection was common in our study population using both PCR and HC. Our data showing 84% positivity using HC are similar to the 74% rate in men with AIDS/ARC reported in a recent study'5 using the Virapap/ViraType technique. Similar to earlier studies, low CD4 counts and HPV infection were associated with abnormal anal cytology in our study. This is especially significant given the low mean CD4 counts in our study population. Oral thrush, a clinical marker of advanced immunosuppression, was also associated with abnormal cytology. Concurrent infection with one or more HPV types from both the HC A and B groups was associated with the highest risk for abnormal cytology. 
